$24.43
1.69% day before yesterday
NYSE, Nov 07, 10:13 pm CET
ISIN
US7170811035
Symbol
PFE

Pfizer Stock price

$24.43
-1.84 7.00% 1M
+1.64 7.20% 6M
-2.10 7.92% YTD
-3.03 11.03% 1Y
-22.66 48.12% 3Y
-12.70 34.21% 5Y
-7.45 23.36% 10Y
+3.33 15.80% 20Y
NYSE, Closing price Fri, Nov 07 2025
-0.42 1.69%

New AI Insights on Pfizer Insights AI Insights on Pfizer

How does the company make money?
Who are the company’s main competitors?

Key metrics

Basic
Market capitalization
$138.9b
Enterprise Value
$185.6b
Net debt
$46.7b
Cash
$15.0b
Shares outstanding
5.7b
Valuation (TTM | estimate)
P/E
14.2 | 8.0
P/S
2.2 | 2.2
EV/Sales
3.0 | 2.9
EV/FCF
17.9
P/B
1.5
Dividends
DPS
$1.69
Yield 1Y | 5Y
6.9% | 4.2%
Growth 1Y | 5Y
2.4% | 4.1%
Payout 1Y | 3Y
119.9% | 68.3%
Increased
15 Years
Financials (TTM | estimate)
Revenue
$62.8b | $63.5b
EBITDA
$23.3b | $24.4b
EBIT
$18.3b | $21.9b
Net Income
$9.8b | $17.5b
Free Cash Flow
$10.4b
Growth (TTM | estimate)
Revenue
3.9% | -0.2%
EBITDA
-5.3% | 10.7%
EBIT
-5.8% | 30.8%
Net Income
131.1% | 117.6%
Free Cash Flow
26.1%
Margin (TTM | estimate)
Gross
75.0%
EBITDA
37.1% | 38.4%
EBIT
29.1%
Net
15.7% | 27.5%
Free Cash Flow
16.5%
Financial Health
Equity Ratio
41.3%
Return on Equity
9.1%
ROCE
10.6%
ROIC
12.0%
Debt/Equity
0.7
More
EPS
$1.7
FCF per Share
$1.8
Short interest
2.1%
Employees
81k
Rev per Employee
$790.0k
Show more

Is Pfizer a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,024 stocks worldwide.

Pfizer Stock Analysis

Unlock Scores for Free

Analyst Opinions

30 Analysts have issued a Pfizer forecast:

14x Buy
47%
15x Hold
50%
1x Sell
3%

Analyst Opinions

30 Analysts have issued a Pfizer forecast:

Buy
47%
Hold
50%
Sell
3%

Financial data from Pfizer

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
62,786 62,786
4% 4%
100%
- Direct Costs 15,727 15,727
34% 34%
25%
47,059 47,059
3% 3%
75%
- Selling and Administrative Expenses 13,836 13,836
7% 7%
22%
- Research and Development Expense 10,132 10,132
3% 3%
16%
23,287 23,287
5% 5%
37%
- Depreciation and Amortization 5,004 5,004
4% 4%
8%
EBIT (Operating Income) EBIT 18,283 18,283
6% 6%
29%
Net Profit 9,828 9,828
131% 131%
16%

In millions USD.

Don't miss a Thing! We will send you all news about Pfizer directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Pfizer Stock News

Neutral
New York Post
about 10 hours ago
Metsera accepted a sweetened offer from Pfizer late on Friday, citing U.S. antitrust risks in Novo's bid that it had previously called superior.
Positive
Invezz
about 17 hours ago
Pfizer acquires Metsera for $10 billion, cementing their new obesity treatment strategy. The purchase concludes a weeklong bidding frenzy between the New York-based pharmaceutical company and Danish heavyweight Novo Nordisk, whose last-minute counterbid was finally rejected by US antitrust regulators.
Positive
The Motley Fool
about 17 hours ago
Coca-Cola owes its remarkable dividend streak to its brand name, pricing power, and new products. Pfizer is struggling right now, but its future looks bright considering recent moves and a cheap valuation.
More Pfizer News

Company Profile

Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Head office United States
CEO Albert Bourla
Employees 81,000
Founded 1849
Website www.pfizer.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today